[1]
“Comment on the ‘Use of intravenous immunoglobulin for the treatment of severe COVID-19’”, South Afr J Crit Care, vol. 41, no. 3, p. e3107, Dec. 2025, doi: 10.7196/SAJCC.2025.v41i3.3107.